Atlas Trials

SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors

Clinical trial NCT07341321 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07341321
Sponsor
Medical University of Graz
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
mRNA VaccinationHepatocellular CarcinomaCheckpoint Inhibitor
Start date
2026-01-01
Primary completion
2026-07-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.